Dr Lance Liotta, Professor of Life Sciences and Co-Director at the Center for Applied Proteomics and Molecular Medicine, George Mason University (VA, USA)
Personalizing cancer therapy
We have recently launched a novel personalised therapy clinical trial to treat patients with late-stage colorectal cancer at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM). This is one of the most cutting-edge personalised therapy clinical trials in the world for several reasons including